SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-22-037226
Filing Date
2022-10-14
Accepted
2022-10-14 16:01:49
Documents
13
Period of Report
2022-09-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A brhc10042873_8ka.htm   iXBRL 8-K/A 29511
2 EXHIBIT 23.1 brhc10042873_ex23-1.htm EX-23.1 3135
  Complete submission text file 0001140361-22-037226.txt   170804

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lsta-20220914.xsd EX-101.SCH 3869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lsta-20220914_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lsta-20220914_pre.xml EX-101.PRE 16047
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10042873_8ka_htm.xml XML 4236
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33650 | Film No.: 221311331
SIC: 8090 Services-Misc Health & Allied Services, NEC